NCCAM Sponsoring First Glucosamine/Chondroitin Sulfate Multicenter Study
This article was originally published in The Tan Sheet
Executive Summary
NCCAM is sponsoring the first U.S. multicenter study investigating the "short-term (16 weeks) effectiveness of glucosamine and chondroitin sulfate in reducing pain and improving function in a large number of patients with osteoarthritis of the knee," the National Institutes of Health National Center for Complementary & Alternative Medicine announced.
You may also be interested in...
Glucosamine/Chondroitin Supplier Selection Delays NIH Study
Difficulty in choosing a U.S. company to supply glucosamine and chondroitin sulfate has delayed the start of the NIH-funded study on osteoarthritis.
Five Of 32 Chondroitin Products Tested Met Label Claims - JANA Study
Amounts of glucosamine and chondroitin in dietary supplements analyzed for content differed significantly from the levels claimed on labeling "with deviations...ranging from as low as 0% to over 115%," Natalie Eddington, PhD, et al., University of Maryland School of Pharmacy, report.
Glucosamine/Chondroitin OA Long-Term Efficacy Not Known - JAMA Article
The long-term efficacy and toxicity of popular supplement ingredients glucosamine and chondroitin for treatment of osteoarthritis (OA) symptoms has not been established, Tanveer Towheed, MD, and Tassos Anastassiades, MD, Queen's University, Kingston, Ontario, state in an editorial published in the March 15 issue of the Journal of the American Medical Association.